Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiplatelet Therapy”

520 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 520 results

Not applicableNot Yet RecruitingNCT07125651
What this trial is testing

Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.

Who this might be right for
Gastro Intestinal BleedingIschaemic Heart DiseasesAntiplatelet Drugs+1 more
Assiut University 112
Not applicableStudy completedNCT00352014
What this trial is testing

Evaluation and Comparison of Several Point-of-care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-treated Patients Undergoing Elective PCI.

Who this might be right for
Stable Angina Pectoris
R&D Cardiologie 1,000
Early research (Phase 1)Study completedNCT02554721
What this trial is testing

Pharmacodynamic Study of Cilostazol in Healthy Volunteers

Who this might be right for
Healthy
Otsuka Pharmaceutical Co., Ltd. 77
Very early researchStudy completedNCT04822363
What this trial is testing

The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry

Who this might be right for
Platelet Activation Testing Before/After Anti-platelet TherapyHealthy
Beth Israel Deaconess Medical Center 112
Not applicableStudy completedNCT06177587
What this trial is testing

Multimarker Evaluation of Platelet Activity and Agregation in ACS

Who this might be right for
Acute Coronary Syndrome
Medical University of Warsaw 150
Post-approval studies (Phase 4)Study completedNCT02219412
What this trial is testing

Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy

Who this might be right for
Coronary Heart Disease
Yong Huo 70
Post-approval studies (Phase 4)Study completedNCT01106534
What this trial is testing

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

Who this might be right for
Chronic Total Occlusion of Coronary ArteryVascular DiseaseMyocardial Ischemia+4 more
Abbott Medical Devices 870
Not applicableLooking for participantsNCT06301776
What this trial is testing

A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge

Who this might be right for
Brain DiseaseVertebral Artery Stenosis
The Fourth Affiliated Hospital of China Medical University 560
Large-scale testing (Phase 3)UnknownNCT00125671
What this trial is testing

Warfarin and Antiplatelet Vascular Evaluation

Who this might be right for
Peripheral Vascular DiseasesCardiovascular Diseases
Anand, Sonia, M.D. 2,400
Not applicableStudy completedNCT03848572
What this trial is testing

Repetitive Assessement of PRECISE-DAPT Score

Who this might be right for
Cardiovascular DiseasesInterventional Cardiology
University of Roma La Sapienza 500
Large-scale testing (Phase 3)Looking for participantsNCT05387954
What this trial is testing

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Who this might be right for
Cryptogenic Ischemic StrokePatent Foramen Ovale
Assistance Publique - Hôpitaux de Paris 792
Post-approval studies (Phase 4)Looking for participantsNCT06691191
What this trial is testing

Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors

Who this might be right for
Coronary Artery Disease
University of Florida 48
Testing effectiveness (Phase 2)Ended earlyNCT00546260
What this trial is testing

Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

Who this might be right for
Myocardial Infarction
Portola Pharmaceuticals 70
Not applicableStudy completedNCT02979158
What this trial is testing

Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass

Who this might be right for
Cardiopulmonary BypassPlatelet DisorderBleeding Disorder+1 more
Umeå University 60
Not applicableLooking for participantsNCT06474884
What this trial is testing

The Safety and Efficacy of Single Antiplatelet Therapy After Pipeline Flex with Shield for Intracranial Aneurysms

Who this might be right for
Treatment
Xuanwu Hospital, Beijing 165
Testing effectiveness (Phase 2)Study completedNCT00528411
What this trial is testing

The Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Who this might be right for
Coronary Artery Disease
AstraZeneca 123
Testing effectiveness (Phase 2)Study completedNCT02559414
What this trial is testing

Antiplatelet Therapy in HIV

Who this might be right for
HIVCardiovascular DiseasesInflammation
NYU Langone Health 55
Large-scale testing (Phase 3)Study completedNCT02664649
What this trial is testing

Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis

Who this might be right for
Symptomatic Aortic StenosisEligible for Transcatheter Aortic Valve Replacement
Assistance Publique - Hôpitaux de Paris 1,510
Large-scale testing (Phase 3)UnknownNCT05903976
What this trial is testing

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS

Who this might be right for
Dual Antiplatelet TherapyAcute Coronary SyndromeCoronary Artery Disease
Azienda Ospedaliera Universitaria Policlinico "G. Martino" 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07467213
What this trial is testing

Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction (AMI)Gastrointestinal Bleeding
Samsung Medical Center 5,000
Load More Results